Elafibranor Improves Biochemical Response and Prognostic Scores in Primary Biliary Cholangitis
In the phase III ELATIVE trial, 52 weeks of elafibranor improved biochemical response rates across all criteria and favorably modified ...
In the phase III ELATIVE trial, 52 weeks of elafibranor improved biochemical response rates across all criteria and favorably modified ...
A study in Breast Cancer Research found that metabolic response measured by FDG-PET/CT is associated with longer progression-free survival in ...
A systematic review and dose-response meta-analysis reveals a nonlinear relationship between serum adalimumab concentrations and clinical response in rheumatoid arthritis, ...
A new study published in Discover Atmosphere reveals that India's Graded Response Action Plan, or GRAP, provides only limited and ...
A forty-three-year econometric evaluation reveals that India's minimum support prices exerted only modest, transitory influences on national agricultural crop acreage ...
A prospective multicenter cohort study evaluates whether plasma-derived extracellular vesicles can predict response to anti-PD-(L)1 therapies in patients with advanced ...
A systematic review and meta-analysis of twelve studies revealed that supervised machine learning models achieved a pooled AUROC of 0.84 ...
A methodological critique highlights potential analytic biases behind reported increases in acute renal failure and deep venous thrombosis following aneurysmal ...
A prospective multicenter study subgroup analysis examined immunosuppressive therapy discontinuation in kidney transplant recipients with sepsis, finding consistent outcomes across ...
An exploratory secondary analysis of a randomized controlled trial found no robust or consistent baseline predictors of clinical improvement following ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine